In a study published in Nature Communications, a team of researchers developed a new approach that can isolate biomarkers released from glioblastoma tumor cells.

They showed that their method can be used to determine the effectiveness of the chemotherapy drug paclitaxel.

The Jackson Laboratory (JAX) and the New York Stem Cell Foundation (NYSCF) today celebrated the official launch of their unified organization with a ribbon-tying ceremony at NYSCF’s Manhattan research facilities. This milestone marks a strategic acquisition designed to transform early-stage biomedical discovery and speed the path from biological insights to new therapies. 

A flutter of blue and yellow darts through a field in late May. Trees, shrubs and summer flowers fill the landscape. A blue-winged warbler is just within reach, with one swift motion it can be gently grasped, banded and studied to understand the health and evolution of one of North America’s most colorful birds. A practice once reserved for scientists, this moment is now possible anywhere in the world thanks to a virtual reality experience developed by scientists at Penn State.    

After analyzing over 1,400 cases of squamous cell carcinoma of the head and neck, the study found that more aggressive histopathological variants occur at a rate of 4.6%. Previous estimates pointed to a rate of up to 15%.

A novel analysis investigating the contribution of social determinants of health (SDoH) to cardiac aging has found that financial strain and food insecurity are the strongest drivers of accelerated biological aging and increased mortality risk. The study in Mayo Clinic Proceedings, published by Elsevier, underscores the complexity and interplay of novel social risk factors that may contribute to cardiovascular events and emphasizes the need for targeted preventive interventions and patient-centered care.